177 related articles for article (PubMed ID: 25045718)
1. Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies.
Tamošiūnas PL; Petraitytė-Burneikienė R; Lasickienė R; Akatov A; Kundrotas G; Sereika V; Lelešius R; Žvirblienė A; Sasnauskas K
J Immunol Res; 2014; 2014():573531. PubMed ID: 25045718
[TBL] [Abstract][Full Text] [Related]
2. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine.
Chen Y; Guo W; Xu Z; Yan Q; Luo Y; Shi Q; Chen D; Zhu L; Wang X
Virol J; 2011 Jun; 8():307. PubMed ID: 21679423
[TBL] [Abstract][Full Text] [Related]
3. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
[TBL] [Abstract][Full Text] [Related]
4. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
[TBL] [Abstract][Full Text] [Related]
5. [Immune Response of Recombinant Pseudorabies Virus rPRV-VP2 Expressing VP2 Gene of Porcine Parvovirus in Mice].
Fu P; Pan X; Han Q; Yang X; Zhu Q; Guo X; Zhang Y; Chen H
Bing Du Xue Bao; 2016 Mar; 32(2):195-202. PubMed ID: 27396164
[TBL] [Abstract][Full Text] [Related]
6. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
[TBL] [Abstract][Full Text] [Related]
7. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
[TBL] [Abstract][Full Text] [Related]
8. [Co-expression of CSFV T cell epitope E290 peptide and PPV VP2 protein in Lactobacillus casei and determination of specific antibodies in immunized mice].
Xu YG; Cui LC; Ge JW; Zhao LL; Li YJ
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):667-72. PubMed ID: 17944369
[TBL] [Abstract][Full Text] [Related]
9. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
[TBL] [Abstract][Full Text] [Related]
10. Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.
Pan Q; He K; Wang Y; Wang X; Ouyang W
Virus Genes; 2013 Jun; 46(3):465-72. PubMed ID: 23430711
[TBL] [Abstract][Full Text] [Related]
11. Identification of a dominant linear epitope on the VP2 capsid protein of porcine parvovirus and characterization of two monoclonal antibodies with neutralizing abilities.
Liu Y; Wang J; Chen Y; Wang A; Wei Q; Yang S; Feng H; Chai S; Liu D; Zhang G
Int J Biol Macromol; 2020 Nov; 163():2013-2022. PubMed ID: 32931829
[TBL] [Abstract][Full Text] [Related]
12. Expression and self-assembly of virus-like particles from porcine parvovirus and its application in antibody detection.
Li Y; Wang Q; Yue W; Li X; Chen Y; Gao Y
Pol J Vet Sci; 2023 Dec; 26(4):591-609. PubMed ID: 38088304
[TBL] [Abstract][Full Text] [Related]
13. Identification of three PPV1 VP2 protein-specific B cell linear epitopes using monoclonal antibodies against baculovirus-expressed recombinant VP2 protein.
Sun J; Huang L; Wei Y; Wang Y; Chen D; Du W; Wu H; Feng L; Liu C
Appl Microbiol Biotechnol; 2015 Nov; 99(21):9025-36. PubMed ID: 26153140
[TBL] [Abstract][Full Text] [Related]
14. [Eukaryotic expression of NS1 major antigen region of PPV and development of an indirect ELISA based on the expressed protein].
Ma H; Zhao XY; Bian CZ
Bing Du Xue Bao; 2012 Nov; 28(6):628-32. PubMed ID: 23367561
[TBL] [Abstract][Full Text] [Related]
15. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a recombinant pseudorabies virus expressing porcine parvovirus VP2 protein and porcine IL-6.
Zheng HH; Wang LQ; Fu PF; Zheng LL; Chen HY; Liu F
Virol J; 2020 Feb; 17(1):19. PubMed ID: 32014014
[TBL] [Abstract][Full Text] [Related]
17. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.
Pan Q; He K; Huang K
Vaccine; 2008 Apr; 26(17):2119-26. PubMed ID: 18378364
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of the rVP-ELISA for detection of antibodies against porcine parvovirus.
Kong M; Peng Y; Cui Y; Chang T; Wang X; Liu Z; Liu Y; Zhu Y; Luo Y; Tang Q; Feng L; Cui S
J Virol Methods; 2014 Sep; 206():115-8. PubMed ID: 24945904
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembly of Porcine Parvovirus Virus-like Particles and Their Application in Serological Assay.
Gao Y; Wang H; Wang S; Sun M; Fang Z; Liu X; Cai X; Tu Y
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
